Dana Goldman

Dana Goldman is the Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics at the University of Southern California. He is also a nonresident senior fellow at The Brookings Institution and research associate with the National Bureau for Economic Research. For the past 10 years, he has led USC’s Schaeffer Center for Health Policy and Economics, one of the nation’s premier health policy programs within the Price School of Public Policy and School of Pharmacy. Professor Goldman will be serving as Interim Dean of the Sol Price School starting July 1, 2020.

He is the author of approximately 300 articles and book chapters in medicine, health policy, economics, and statistics. Professor Goldman pioneered a “Netflix model” to improve access to prescription drugs and the value of reduced copayments for the chronically ill. He has served as a health policy advisor to the Congressional Budget Office, Covered California, Fred Hutchinson Cancer Institute, and National Institutes of Health. He is a founding editor of the Forum for Health Economics and Policy and serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is a former director of the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Dr. Goldman's research and opinion pieces have appeared in the New York Times, Wall Street Journal, Washington Post, Stat, Forbes, Business Week, U.S. News & World Report, The Economist, NBC Nightly News, PBS NewsHour, CNN, NPR, and other media.

Professor Goldman is an elected member of the National Academy of Medicine and the National Academy of Social Insurance. In 2016, he was appointed a Distinguished Professor at the University of Southern California in honor of accomplishments bringing the University “special renown.” He received the MetLife Foundation Silver Scholar Award in honor of his research to value healthy aging and medical innovations; the Eugene Garfield Economic Impact Prize, recognizing outstanding work demonstrating how medical research impacts the economy; the National Institute for Health Care Management Research Foundation award for excellence in health policy; and the Alice S. Hersh New Investigator Award recognizing contributions of a young scholar to health services research.

Professor Goldman advises many companies in the life sciences industry. He was a co-founder of Precision Health Economics in 2006—a consultancy that provides analytic services to pharmaceutical, biological and health care companies—and currently serves as a scientific advisor. He also spent 15 years at the RAND Corporation, where he held the Distinguished Chair in Health Economics and served as director of its health economics program and the Bing Center. He formerly served on the Scientific Advisory Board of ACADIA Pharmaceuticals, and currently serves on GRAIL’s Scientific Advisory Board.

Professor Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.